Senior Executive Breakfast: 'The Importance of Embracing Big Data' Kindly Supported by Penningtons Manches

Big data in life sciences is overwhelming, not only because of its volume but also because of the diversity of data types and the speed at which it must be managed. The industry generates huge amounts of data, driven by research, patient profiling, compliance and regulatory requirements.

With data growing exponentially, it is important for companies to embrace big data analytics to transform the way they gain insights from their clinical and data repositories, and thus make better informed decisions.

The benefits of digital experimentation include:

• Enhanced predictive modelling to produce leaner, faster, more targeted R&D pipelines in drugs and devices
• Leveraging statistical tools and algorithms to improve clinical trial design and patient recruitment
• Improved identification of adverse effects before a product reaches market

However, for a company to successfully embrace big data, they must have a sound strategy, collaborative culture, and supportive leadership, with challenges to successful implementation including:

• How to identify the right priorities, and which technology should be used e.g. AI, blockchain, VR, cloud computing?
• A lack of experience and existing talent within an organisation
• The importance of good data governance to guarantee privacy and security
• Do you have the funds available to invest in new tools and technologies?

But does the potential of acquiring the available tools for data preparation, integration, quality and protection outweigh the challenges? Our panel of industry experts will discuss this and more on Thursday 7 March.

Agenda

8:30 Registration, breakfast and networking

9:00 Welcome and introductions from OBN and Penningtons Manches

9:10 Keynote presentations:
Ewa Truchanowicz, Director Business Development at Dignio
Jonny Wray, Head of Discovery Informatics at e-therapeutics
Mark Swindells, COO at Exscientia
Chris Shelley, Partner at Penningtons Manches

10:00 Roundtable Q&A

10:30 Event close